nalidixic acid has been researched along with sulfamethoxypyridazine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Videau, D | 1 |
| Jackson, EA; McLeod, DC | 1 |
| Bourse, R; Moatti, N; Monnier, J; Suc, C | 1 |
6 other study(ies) available for nalidixic acid and sulfamethoxypyridazine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Experimental pyelonephritis in rats: value in the comparison of antibiotics (author's transl)].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cefazolin; Cephaloridine; Cephalothin; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Female; Injections, Intramuscular; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Nalidixic Acid; Nitroquinolines; Pyelonephritis; Rats; Rifampin; Sulfamethoxypyridazine; Urine | 1976 |
Pharmacokinetics and dosing of antimicrobial agents in renal impairment, Part II.
Topics: Anti-Infective Agents; Bacitracin; Chloramphenicol; Chloroquine; Clindamycin; Dapsone; Ethambutol; Humans; Isoniazid; Kidney Diseases; Methenamine; Nalidixic Acid; Neomycin; Nitrofurantoin; Sulfadimethoxine; Sulfamethizole; Sulfamethoxazole; Sulfamethoxypyridazine; Sulfisomidine; Sulfisoxazole; Vancomycin | 1974 |
[Comparative theoretical activity of antibiotics on the main gram-negative bacilli].
Topics: Anti-Bacterial Agents; Cephalosporins; Colistin; Enterobacter; Escherichia coli; Gentamicins; Kanamycin; Klebsiella; Nalidixic Acid; Nitrofurantoin; Penicillins; Proteus; Pseudomonas aeruginosa; Streptomycin; Sulfamethoxypyridazine; Tetracycline | 1969 |
[Antibiotic treatment in the perinatal period].
Topics: Anti-Bacterial Agents; Bacteriuria; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin; Maternal-Fetal Exchange; Methicillin; Nalidixic Acid; Nitrofurantoin; Obstetric Labor Complications; Obstetric Labor, Premature; Oxacillin; Penicillin G; Pregnancy; Pregnancy Complications, Infectious; Pyelonephritis; Staphylococcal Infections; Streptomycin; Sulfamethoxypyridazine; Umbilical Cord; Urinary Tract Infections | 1969 |